共 50 条
Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma
被引:24
|作者:
Tarasova, V. D.
[1
]
Tuttle, R. M.
[1
]
机构:
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA
关键词:
Low risk thyroid cancer;
papillary microcarcinoma;
staging;
BRAF V600E MUTATION;
ACTIVE SURVEILLANCE;
RADIOACTIVE IODINE;
CARCINOMA;
ASSOCIATION;
RECURRENCE;
STRATIFICATION;
SURGERY;
PROGNOSIS;
IMPACT;
D O I:
10.1016/j.clon.2016.12.009
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Each year, the proportion of thyroid cancer patients presenting with low risk disease is increasing. Moreover, the definition of low risk thyroid cancer is expanding and several histological subtypes beyond papillary microcarcinomas are now classified as low risk disease. This shift in the landscape of thyroid cancer presentation is forcing clinicians to critically re-evaluate whether or not traditional management paradigms that were effective in treating intermediate and high risk disease are applicable to these low risk patients. Here we review the definition of low risk disease, examine the various histological subtypes that are considered low risk in the 2015 American Thyroid Association guidelines for the management of thyroid nodules and thyroid cancer, and review our current approach to the management of these low risk tumours. (C) 2016 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:290 / 297
页数:8
相关论文